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Stem cells reside in a microenvironment or niche that is critical for stem cell maintenance 
and regulation. But what happens when a stem cell niche is disrupted? In this issue of Cell, 
two reports (Walkley et al., 2007a, 2007b) demonstrate in mice that alterations in the niche 
for hematopoietic stem cells lead to the development of myeloproliferative disease.Hematopoietic stem cells (HSCs) are 
maintained and regulated in microenvi-
ronments or niches in the bone marrow. 
HSCs are known to reside in two differ-
ent niches, an “osteoblastic” niche and 
a “vascular” niche. In the osteoblastic 
niche, HSCs are associated with a sub-
set of osteoblasts (the cells responsible 
for bone formation) that line the inner 
surface of the bone cavity (Calvi et al., 
2003; Zhang et al., 2003; Arai et al., 
2004). In contrast, in the vascular niche, 
HSCs associate with the surfaces of 
endothelial cells that line the sinusoids 
of bone marrow and spleen (Kiel et 
al., 2005). Recently, it was shown that 
CXCL12-abundant reticular (CAR) cells 
are found in association with HSCs 
in both the osteoblastic and vascular 
niches (Sugiyama et al., 2006) and may 
serve as a transit pathway for shuttling 
HSCs between the two. It has been 
proposed that these two niches are 
functionally distinct: the osteoblastic 
niche is thought to maintain HSC qui-
escence over the long term, whereas 
the vascular niche is thought to main-tain HSCs over a shorter time period, 
supporting HSC proliferation, favoring 
myeloid and megakaryocytic lineage 
differentiation, and mediating HSC 
circulation (Kopp et al., 2005). Despite 
the critical role of these two niches in 
regulating HSCs, evidence for a role of 
the niche in disease has been limited. 
In this issue of Cell, Orkin, Purton, and 
their colleagues demonstrate in mice 
that the microenvironment can play a 
dominant role in the development of 
myeloproliferative disease—a disorder 
characterized by the neoplastic devel-
opment of myeloid cells (Walkley et al., 
2007a, 2007b) (Figure 1).
Given that key cell cycle regula-
tors have been implicated in HSC 
dysfunction, Orkin and colleagues 
first examined loss of the retinoblas-
toma (RB) protein, a cell cycle regu-
lator and tumor suppressor, in the 
hematopoietic system (Walkley et al., 
2007a). Surprisingly, RB was found to 
be dispensable for self-renewal and 
multilineage differentiation of HSCs. 
However, widespread loss of RB in the Cell 129, Jhematopoietic system results in extra-
medullary hematopoiesis (hematopoi-
esis outside of the bone marrow, for 
instance, in the spleen). These mice 
eventually develop myeloproliferative 
disease. Strikingly, myeloid-specific 
loss of RB resulted in only mild defects 
and did not result in myeloprolifera-
tive disease or HSC abnormalities, 
suggesting that the defect resulting 
from widespread loss of RB is not 
solely caused by myeloid cells with 
intrinsic RB deficiency or by myeloid 
cells derived from RB-deficient HSCs. 
Furthermore, transplantation of nor-
mal hematopoietic cells into an RB-
deficient microenvironment failed to 
recapitulate the effects observed with 
widespread deletion of RB. Only when 
myeloid-specific loss of RB was com-
bined with loss of RB in the microenvi-
ronment was the full myeloproliferative 
defect recapitulated. Thus, the myelo-
proliferative disease observed with 
widespread loss of RB resulted from 
an interaction between myeloid cells 
and the altered microenvironment.une 15, 2007 ©2007 Elsevier Inc. 1045
Figure 1. Alterations to the Stem Cell Niche Lead to Myeloproliferative Disease
(Top) In normal bone marrow, the osteoblastic niche (tan) maintains hematopoietic stem cells (HSCs) 
(red) in a quiescent state. Endothelial cells line the bone marrow and spleen sinusoids CXCL12-abun-
dant reticular (CAR) cells (yellow) are found in association with HSCs in both the osteoblastic and vas-
cular niches (Sugiyama et al., 2006) and may serve as a transit pathway for shuttling HSCs between 
the osteoblastic and vascular niches where essential but different maintenance signals are provided. 
(Middle) Loss of RB expression in the microenvironment and myeloid cells leads to degradation 
of the osteoblastic niche by osteoclasts (Walkley et al., 2007a). HSCs are now displaced from 
their homeostatic niche and undergo expansion and mobilization to the spleen, where myeloid 
development predominates, eventually resulting in myeloproliferative disease. Eventually, HSCs are 
exhausted, resulting in bone marrow failure. (Bottom) RARγ deficiency also results in depletion of 
the osteoblastic niche (Walkley et al., 2007b). Here, myeloid progenitors (blue) predominate and un-
dergo massive expansion in the spleen. HSCs are maintained in the vascular niche, but excessive 
myelopoiesis in bone marrow and spleen leads to myeloproliferative disease.Osteoclasts, which are the cells 
involved in bone resorption, belong to 
the myeloid cell family. The number of 
osteoclasts increased dramatically fol-
lowing the loss of RB, which resulted in 
depletion of osteoblasts. Indeed, his-
topathology of bone sections showed 
that RB deficiency resulted in a loss of 
trabecular bone, the primary site of the 
osteoblastic niche. Thus, it appears 
that RB loss ultimately results in loss 
of the niche, which is thought to main-1046 Cell 129, June 15, 2007 ©2007 Elsetain HSC quiescence, leading to HSC 
mobilization and extramedullary hema-
topoiesis, possibly setting the stage for 
myeloproliferative disease.
In a complementary study, Purton 
and colleagues examined the effects 
of retinoic acid receptor γ (RARγ) defi-
ciency on the hematopoietic system 
of mice (Walkley et al., 2007b). RARγ 
deficiency also resulted in myelopro-
liferative disease. In this case, the dis-
ease was due entirely to deficiency vier Inc.of RARγ in the microenvironment. As 
with the loss of RB, RARγ deficiency 
also led to a reduction in trabecu-
lar bone. Could loss or reduction of 
the osteoblastic niche link these two 
models of myeloproliferative disease? 
Although this is an important connec-
tion between the two models, the story 
is more complicated. Older mice lack-
ing RARγ exhibit nearly complete loss 
of trabecular bone and also exhibit 
mobilization of HSCs to the spleen, 
but the defect is reported to stem pri-
marily from relatively mature myeloid 
progenitor cells. Nonetheless, subtle 
defects in more primitive hematopoi-
etic stem and progenitor cells may be 
the root cause of disease in this model. 
However, unlike the RB model system, 
which exhibits hematopoietic failure, 
HSCs are retained in the bone marrow 
of RARγ-deficient mice and continue to 
support hematopoiesis for months. It is 
unclear why the vascular niche fails to 
maintain HSCs in the RB model and in 
other models in which osteoblasts are 
severely reduced. However, it is likely 
that loss of RB or RARγ has broad 
effects on the microenvironment that 
are not limited to a reduction in the 
osteoblastic niche. Indeed, Purton and 
colleagues demonstrate this by show-
ing that the effect of RARγ deficiency 
in the microenvironment is reduced in 
mice that receive transplants of TNFα 
null HSCs as compared to wild-type 
HSCs, although the reason for this is 
not clear. Even though HSCs are main-
tained for months despite a severe 
reduction in the osteoblastic niche, the 
consequences of this changed micro-
environmental regulation of HSCs in 
the RARγ-deficient mice likely sets the 
stage for development of myeloprolif-
erative disease.
Myeloproliferative disease, although 
not malignant, is a preleukemic con-
dition. Thus, these findings raise the 
question of whether changes in the 
HSC niche have a role in hematopoietic 
malignancy. Although neither model 
reported here results in leukemic trans-
formation, evidence that the microenvi-
ronment contributes to tumorigenesis 
is accumulating. It has been proposed 
that many cancers are derived from and 
supported by cancer stem cells. Can-
cer stem cells are derived from normal 
stem cells and have uncontrolled self-
renewal capability that is independent 
of the niche. Alternatively, progenitors 
may inappropriately retain or acquire 
self-renewal capacity and become can-
cer stem cells. A complementary con-
cept of a tumorigenic niche has been 
proposed (Flynn and Kaufman, 2007; 
Li and Neaves, 2006). Niche dysfunc-
tion could contribute to tumorigenesis 
in several ways. For instance, a tumori-
genic niche could supply inappropri-
ate levels of growth factors that either 
promote proliferation and/or inhibit 
apoptosis. Indeed, bone marrow is a 
preferred site for metastasis of certain 
cancers (Jones et al., 2006). In addi-
tion, an important difference between 
normal and neoplastic HSCs is their 
degree of dependence on the niche. 
The osteoblastic niche is thought to 
maintain HSC quiescence by provid-
ing signals that inhibit proliferation. 
Thus, loss of this niche as reported in 
the RB- and RARγ-deficient mice may 
lead to stem cell (or its derived pro-
genitor cell) expansion due to the loss 
of inhibitory signals normally provided 
by the osteoblastic niche. Mobilization Centromeres are special chromosome 
loci where kinetochores are assembled 
during mitosis and meiosis. All eukary-
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Three recent papers, including 
protein Scm3 is required for the
budding yeast. Scm3 forms a ch
to lack H2A/H2B histones. The
Cse4 to centromeres and have of stem and progenitor cells, mainly to 
the spleen, may provide a more per-
missive microenvironment favoring 
cellular proliferation and myeloid differ-
entiation that aids in the development 
of myeloproliferative disease. The fact 
that leukemia fails to develop in these 
mouse models suggests that additional 
genetic mutations may be necessary 
for complete transformation. It will be 
important to determine the contribu-
tions of the microenvironment to other 
hematological disorders, as they are 
likely to be significant and may provide 
new targets for therapy. Finally, the effi-
cacy of bone marrow transplantation, 
commonly used to treat many hema-
tological disorders, may be decreased 
in cases where substantial microenvi-
ronmental dysfunction contributes to 
disease. Thus, further knowledge of 
contributions of the stem cell microen-
vironment to disease will be important 
for future clinical progress.
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